[Intratympanic dexamethasone injections for intractable Meniere's disease].

Abstract

OBJECTIVE:

To investigate the efficacy of intratympanic dexamethasone injections (IDI) and intermittent pressure (IP) for 13 patients with intractable Meniere's disease (MD).

METHOD:

Dexamethasone (5 g/L) was injected into the middle ear. The injection was repeated the next day and weekly for 3 weeks. Together with tympanic intermittent pressure (IP).

RESULT:

The 13 patients was followed up for 2-5 years. Complete relief vertigo was maintained in 9 cases,improved in 3 cases. The injection was repeated in 1 patient with recurrent vertigo and total control of vertigo was obtained. Tinnitus disappeared in 5 cases, reduced in 3 case, unchanged in 5 cases. Hearing was improved in 9 cases, unchanged in 4 cases.

CONCLUSION:

IDI and IP are effective for intractable MD. The benefits of IDI and IP are easy application for doctors and reasonable cost which can be accepted by patients easily.

• Authors: Ying Huang, Yu She, Wanrong Li, Chongyi Cheng
• Journal: Lin chuang er bi yan hou ke za zhi = Journal of clinical otorhinolaryngology (Lin Chuang Er Bi Yan Hou Ke Za Zhi) Vol. 19 Issue 16 Pg. 748-9 (Aug 2005) China
• PMID: 16320717 (Publication Type: Clinical Trial, English Abstract, Journal Article)

Chemical References

• Dexamethasone

Topics

• Adult
• Dexamethasone (administration & dosage, therapeutic use)
• Ear, Middle
• Female
• Humans
• Injections, Intralesional
• Male
• Meniere Disease (drug therapy)
• Middle Aged
• Treatment Outcome